|
Patients with T-cell or B-cell lymphoid cancers that have recurred or progressed despite prior chemotherapy will receive the drug ABT-263 orally for up to a year in this phase I/II clinical trial. ... Search for Clinical Trials; NCI's PDQ® Cancer Clinical Trials Registry. Non-Hodgkin Lymphoma Home Page; NCI's gateway...
|
www.cancer.gov/clinicaltrials/ft-NCI-07-C-0006
www.cancer.gov/clinicaltrials/ft-NCI-07-C-0006
|
|
|
|
|
Questions about cancer?; ... 1-800-4-CANCER; ... National Cancer Institute...
|
www.cancer.gov/dictionary/?CdrID=46298
www.cancer.gov/dictionary/?CdrID=46298
|
|
|
|
cancer induces complications such as anemia, this aggressive form of therapy may also serve to only further complicate the anemic state. In addition to the cancer related treatments, patients with lymphoid cancer often find they experience the development of other types of cancers at some point in their lives.
|
www.associatedcontent.com/article/436663/lymphoid_cance...
www.associatedcontent.com/article/436663/lymphoid_cancer_the_lifelong_risk_for.html
|
|
|
"The change of levels of CDK9 and CYCLIN T1 in lymphoid cells shows a correlation with activity of the cancer. The higher the expression of the gene and the attached molecule in the blood sample, the more likely for lymphoid cancer.";
|
www.medicalnewstoday.com/articles/12787.php
|
|
What is cancer? A tumor or neoplasm is an abnormal growth of tissue in which ... In some instances, though, the terminology used to name cancers can be misleading. For example, the commonly-used term "lymphoma" is used to name a malignant tumor of lymphoid tissue; there is no such thing as a benign lymphoid tumor.
|
www.cvm.tamu.edu/oncology/faq/questions/cancer02.html
www.cvm.tamu.edu/oncology/faq/questions/cancer02.html
|
|
Nemunaitis J; Rabinowe SN; Singer JW; Bierman PJ; Vose JM; Freedman AS; Onetto N; Gillis S; Oette D; Gold M; Fred Hutchinson Cancer Research Center, ... In patients undergoing autologous bone marrow transplantation for lymphoid neoplasia, rhGM-CSF significantly lessens morbidity. Further studies will be required to establish...
|
www.medscape.com/medline/abstract/1903847
|
|
Home page for the Centre for Lymphoid Cancer (CLC) at the British Columbia Cancer Agency (BCCA) in Vancouver. ... The Centre for Lymphoid Cancer (CLC) is located at the BC Cancer Agency's Vancouver Centre. Lymphoid cancer includes lymphoma, myeloma and leukemia. The CLC is a multi-disciplinary research program focused onÂ...
|
www.bccancer.bc.ca/RES/ResearchPrograms/LymphoidCancers...
www.bccancer.bc.ca/RES/ResearchPrograms/LymphoidCancers/
|
|
PURPOSE: This phase I/II trial is studying the side effects of donor white blood cell infusions and interleukin-2 and to see how well they work in treating patients who are undergoing an autologous stem cell transplant for relapsed advanced lymphoid cancer.
|
clinicaltrials.gov/show/NCT00248430
|
|
Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia. ... 1: Cancer Res. 1994 Jul 15;54(14):3934-8. Links ... Children's Cancer Research Institute, St. Anna Kinderspital, Vienna, Austria.
|
www.ncbi.nlm.nih.gov/pubmed/8033117
|
|
